CAMBRIDGE, UK and ALBANY, NY, 05 September 2018: Metrion Biosciences Limited (“Metrion”), the specialist ion channel CRO and drug discovery company, and AMRI, a globa...

Investment in the German CRO, specialized in the preclinical assessment of new anticancer drugs, strengthens Citoxlab’s pharmacology portfolio, which will benefit fro...

(Vienna, 31 August 2018) Anaplastic large-cell lymphomas (ALCL) are rare cancers of the white blood cells. New research from the international ERIA consortium, led by...

Scientists have tested a non-addictive painkiller in primates and found it to be safe and effective. The fact that the compound was successful in a species so closely...

A new pre-clinical study by the Perelman School of Medicine at the University of Pennsylvania has shown the potential of a universal flu vaccine candidate in protecti...

Mushrooms from the Far East area contain the natural chemical compounds, which could be used for the design of the novel drugs with highly specific anti-tumor activit...

Acute myeloid leukemia is one of the most aggressive cancers. While other cancers have benefitted from new treatments, there has been no encouraging news for most leu...

Researchers at The University of Texas at Austin have developed a new approach to treating cancer using enzyme therapy. The enzyme, PEG-KYNase, does not directly kill...

Boston, USA and London, UK, August 29, 2018 / B3C newswire / — Orchard Therapeutics, a leading commercial-stage company dedicated to transforming the lives of patient...

  Dr Angus Morrison (L) and Dr Stuart McElroy (R). NEWHOUSE, UK (29 August 2018): BioAscent Discovery Limited has announced the appointments of Angus Morrison, PhD, a...